These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 39240345

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
    Chu R, Hurwitz S, Tauhid S, Bakshi R.
    BMC Neurol; 2017 Sep 05; 17(1):172. PubMed ID: 28874119
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
    Wang X, Zhu Q, Yan Z, Shi Z, Xu Y, Liu Y, Li Y.
    Mult Scler Relat Disord; 2023 Jul 05; 75():104740. PubMed ID: 37146422
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
    Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Vrenken H, Leurs CE, Killestein J, Pirpamer L, Enzinger C, Ourselin S, Wheeler-Kingshott CAMG, Chard D, Thompson AJ, Alexander DC, Barkhof F, Ciccarelli O, MAGNIMS study group.
    Ann Neurol; 2018 Feb 05; 83(2):210-222. PubMed ID: 29331092
    [Abstract] [Full Text] [Related]

  • 9. Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
    Gaetano L, Häring DA, Radue EW, Mueller-Lenke N, Thakur A, Tomic D, Kappos L, Sprenger T.
    Neurology; 2018 Apr 10; 90(15):e1324-e1332. PubMed ID: 29540589
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: the impact of thalamic subnuclei on disability.
    Magon S, Chakravarty MM, Amann M, Weier K, Naegelin Y, Andelova M, Radue EW, Stippich C, Lerch JP, Kappos L, Sprenger T.
    Hum Brain Mapp; 2014 Aug 10; 35(8):4193-203. PubMed ID: 24510715
    [Abstract] [Full Text] [Related]

  • 13. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
    Kalinin I, Makshakov G, Evdoshenko E.
    AJNR Am J Neuroradiol; 2020 May 10; 41(5):804-808. PubMed ID: 32381540
    [Abstract] [Full Text] [Related]

  • 14. Deep gray matter atrophy in multiple sclerosis: a tensor based morphometry.
    Tao G, Datta S, He R, Nelson F, Wolinsky JS, Narayana PA.
    J Neurol Sci; 2009 Jul 15; 282(1-2):39-46. PubMed ID: 19168189
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
    Uddin MN, Lebel RM, Seres P, Blevins G, Wilman AH.
    Mult Scler; 2016 Aug 15; 22(9):1133-43. PubMed ID: 26503237
    [Abstract] [Full Text] [Related]

  • 17. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study.
    Hidalgo de la Cruz M, Valsasina P, Meani A, Gallo A, Gobbi C, Bisecco A, Tedeschi G, Zecca C, Rocca MA, Filippi M.
    Mult Scler; 2022 Mar 15; 28(3):406-417. PubMed ID: 34124963
    [Abstract] [Full Text] [Related]

  • 18. Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center data.
    Datta S, Staewen TD, Cofield SS, Cutter GR, Lublin FD, Wolinsky JS, Narayana PA, MRI Analysis Center at Houston, CombiRx Investigators Group.
    Mult Scler Relat Disord; 2015 Mar 15; 4(2):124-36. PubMed ID: 25787188
    [Abstract] [Full Text] [Related]

  • 19. 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions.
    Zurawski J, Tauhid S, Chu R, Khalid F, Healy BC, Weiner HL, Bakshi R.
    Mult Scler; 2020 Feb 15; 26(2):177-187. PubMed ID: 31714181
    [Abstract] [Full Text] [Related]

  • 20. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O'Connor MF, Sicotte NL.
    Neuroimage Clin; 2015 Feb 15; 8():440-7. PubMed ID: 26106524
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.